Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Houssein A. Sater"'
Autor:
Arun Rajan, Renee N Donahue, Jeffrey Schlom, James L Gulley, Elizabeth Lamping, Osama Rahma, Houssein Abdul Sater, Jennifer L Marté, Beatriz Walter-Rodriguez, Yulia Vugmeyster, Yo-Ting Tsai, Shania Bailey, Wiem Lassoued, Richy Agajanian, Andrew Weisman, Rena Ito, Masashi Sato, Andreas Machl
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 3 (2024)
Background Bintrafusp alfa, a first-in-class bifunctional fusion protein targeting transforming growth factor-β (TGF-β) and programmed cell death ligand 1, has demonstrated encouraging efficacy as second-line treatment in patients with non-small ce
Externí odkaz:
https://doaj.org/article/299f4d847daa42ea885a8c75c936bce7
Autor:
James L Gulley, Ravi Madan, Jennifer Marte, Fatima Karzai, Amy Hankin, Houssein Abdul Sater, Manuk Manukyan, William Dahut, Shania Bailey, Wiem Lassoued, Michell Manu, Peter Pinto, Daniel Burnett, Kenneth Canubas, Nikki William
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d25a5872f13a4fdb8aacbef6001b8049
Autor:
James L Gulley, Jennifer Marte, Houssein Abdul Sater, Michael Xu, William Kelly, Wiem Lassoued, Kenneth Canubas
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/51873a19c0b34aad86c8ef3470881f08
Autor:
Ravi Madan, Jennifer Marte, James Gulley, Antonios Papanicolau-Sengos, Fatima Karzai, Amy Hankin, Houssein Abdul Sater, William Dahut, Shania Bailey, Wiem Lassoued, Nikki Williams, Michell Manu, Peter Pinto
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/8e79fc4f580a4855a89071a3c3d4dbd5
Autor:
Renee N Donahue, Jeffrey Schlom, James L Gulley, Christian S Hinrichs, Jay Friedman, Houssein Abdul Sater, Yvette Robbins, Cem Sievers, Paul E Clavijo, Clint Allen, Ke Bai, Andrew Sinkoe, Scott Norberg
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/8d2f6ff3a4b24803a4ce28dc7fc312c6
Autor:
Renee N Donahue, Jeffrey Schlom, James L Gulley, Ravi A Madan, Claudia Palena, Caroline Jochems, Shahrooz Rabizadeh, Patrick Soon-Shiong, Sheri McMahon, Julius Strauss, Marijo Bilusic, Fatima Karzai, Houssein Abdul Sater, Jennifer L Marté, Yo-Ting Tsai, Jason Redman, Charalampos Floudas
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Antitumor vaccines targeting tumor-associated antigens (TAAs) can generate antitumor immune response. A novel vaccine platform using adenovirus 5 (Ad5) vectors [E1–, E2b–] targeting three TAAs—prostate-specific antigen (PSA), brachyu
Externí odkaz:
https://doaj.org/article/0ba9e720c5394549bc0af34acac98f93
Autor:
Ravi Madan, Seth Steinberg, Jung-Min Lee, Marijo Bilusic, Fatima Karzai, Houssein Abdul Sater, Scot Niglio, Jason Redman, Charalampos Floudas, Andrea Apolo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/8f92d05cc5474115bdc78a704b5e3f5b
Autor:
Elizabeth Lamping, Christian S Hinrichs, Edward McClay, Lisa M Cordes, Andrew Hill, Byoung Chul Cho, Sébastien Salas, Laureen S Ojalvo, P Alexander Rolfe, Margaret E Gatti-Mays, Jason M Redman, Houssein A Sater, Andrea Burmeister, Genevieve Jehl
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Bintrafusp alfa is a first-in-class bifunctional fusion protein composed of the extracellular domain of transforming growth factor (TGF)-βRII (a TGF-β ‘trap’) fused to a human IgG1 mAb blocking programmed cell death ligand 1. This is
Externí odkaz:
https://doaj.org/article/8d0952dbd2c84693b0a6b1394990bc11
Autor:
Yvette Robbins, Sarah Greene, Jay Friedman, Paul E Clavijo, Carter Van Waes, Kellsye P Fabian, Michelle R Padget, Houssein Abdul Sater, John H Lee, Patrick Soon-Shiong, James Gulley, Jeffrey Schlom, James W Hodge, Clint T Allen
Publikováno v:
eLife, Vol 9 (2020)
Failed T cell-based immunotherapies in the presence of genomic alterations in antigen presentations pathways may be overcome by NK cell-based immunotherapy. This approach may still be limited by the presence of immunosuppressive myeloid populations.
Externí odkaz:
https://doaj.org/article/c2df21fadf264488a0684e775401ddeb
Autor:
Anson T. Ku, Uma Shankavaram, Shana Y. Trostel, Hong Zhang, Houssein A. Sater, Stephanie A. Harmon, Nicole V. Carrabba, Yang Liu, Bradford J. Wood, Peter A. Pinto, Peter L. Choyke, Radka Stoyanova, Elai Davicioni, Alan Pollack, Baris Turkbey, Adam G. Sowalsky, Deborah E. Citrin
Publikováno v:
medRxiv
STRUCTURED ABSTRACTBackgroundPatients with localized prostate cancer have historically been assigned to clinical risk groups based on local disease extent, serum prostate specific antigen (PSA), and tumor grade. Clinical risk grouping is used to dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0552ceab467acbc6433d0757a0544b43
https://doi.org/10.1101/2023.05.01.23288883
https://doi.org/10.1101/2023.05.01.23288883